IAG . Bankinter Fija su Precio Objetivo en 3,50€ Por Acción . En Marcha la Recompra de Acciones . : PharmaMar Announces Data Presentations For Both Its Molecules Yondelis® , Aplidin Overall survival (OS) results of randomized phase III study (ADMYRE trial) and Lurbinectedin at ASCO 2018 .